Skip to content

Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile Cancer

Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile Cancer

Status
Suspended
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05842031
Enrollment
20
Registered
2023-05-03
Start date
2023-04-14
Completion date
2026-12-31
Last updated
2026-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Penile Cancer

Brief summary

To learn more about the patient experience undergoing inguinal (in the groin) lymph node procedures for penile cancer during and after surgery.

Detailed description

Objectives Primary Objective: To understand the lived experience of patients undergoing invasive inguinal lymph node procedures. Secondary Objective: To determine factors that influence decisions and improve experience for patients who need invasive inguinal lymph node procedures.

Interventions

BEHAVIORALQuality of Life Questionnaires

Identify what interventions may be helpful in improving quality of life.

BEHAVIORALPatient Educational Needs

Identify what interventions may be helpful in improving patient educational needs

BEHAVIORALSymptom Management

Identify what interventions may be helpful in improving symptom management Improve symptom management

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

--Patients diagnosed with penile cancer who have undergone invasive inguinal node procedures (ILND and/or DSNB) and are at least 6 months post-procedure

Exclusion criteria

* Patient's ≤18 years of age * Patients who have not undergone invasive surgical procedures involving the inguinal lymph nodes * Non-English-speaking patients For interviews: people who are physically and/or cognitively incapable of participating in a 60minute telephone interview as determined by a clinical provider or the patient.

Design outcomes

Primary

MeasureTime frameDescription
Decision Regret Scale (DRS) questionnairesthrough study completion; an average of 1 yearScore Scale ranges (1-5) 1. Strongly Agree 2. Agree 3. Agree nor Disagree 4. Disagree 5. Strongly Disagree

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORCurtis Pettaway, BS, MD

MD Anderson

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 15, 2026